Moderna Finance Chief Steps Down After Two Years—But Lands Deal For $42 Million Stock Options

Topline After two years with the vaccine-maker, Moderna’s David Meline will step down as finance chief and retire from the company this summer, but he’ll stay on as a consultant for anothe...